Welcome to issue 72 of Pharmafile, covering topics such as antimicrobial resistance, rare diseases and skin conditions

Somewhere over the redbow, you will find...

Therapeutic Areas in Focus

Editorial Assistant, Ana Ovey introduces the edition, exploring some of the key themes and topics emerging in the issue.

The 2022 International Clinical Researcher of the Year competition is open for entry!

Pharmafile speaks to DeepDrug: DeepDrug tells Pharmafile about the development of new drugs for neglected and infectious diseases, including how AI can be used in the drug development process

Following a global survey on antimicrobial resistance, a global plan has been initiated by WHO, this article explores the further steps that can be taken in AMR planning

Health data systems can be used to directly help patients engage with their care and build trust with their HCPs, this article explores these strategies, placing patient outcomes at the centre of care

Redbow explains their healthcare consultancy strategy and shares details about the company

AI can help infectious diseases remain in the spotlight and help them gain interest from R&D investors, this article explains how

PHARMAFILE SPEAKS TO The Brain Charity: The Brain Charity explain how they've been providing support to patients with rare diseases throughout the COVID-19 pandemic

Ipsen tells Pharmafile about the underestimated impacts of rare and ultra-rare diseases

Pharmafile: Global Pharmaceutical Webinars

Rare and ultra-rare diseases impact a surprising amount of people, this article explores the field of rare diseases as well as the diagnostic journey many patients take

Patients play an important but often forgotten role in drug development, this article considers the significance of patient experience while developing treatments

A lack of research, funding and representation for rare diseases can lead to under diagnosis, this article looks to the future of rare disease treatments

Pharmafilespeaks to Allergy UK: Allergy UK explores the future of eczema diagnosis, treatment, and support

PME: Pharmaceutical Market Europe: Make sure you always have access to your copy of PME!

Skin diseases have many impacts on patients' lives, AbbVie explores these impacts

Organon discusses the ways in which women's skin conditions can be managed

FIDE discuss the need for communication between patients and their HCPs, specifically with virtual platforms in mind, and how this can improve dermatology care

There have been significant advances in dermatological care, this article explores this as well as looking forward to what still needs to be done

The COVID-19 pandemic has been challenging service-wide for the NHS, but the pharma industry can support patients and the NHS going forward

Samedan Ltd: Covering every stage of the supply chain

ICON: Antimicrobial Resistance: How clinical research can combat an ensuing global crisis